Yuhan Corp. - Asset Resilience Ratio

Latest as of December 2025: 0.92%

Yuhan Corp. (000100) has an Asset Resilience Ratio of 0.92% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 000100 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩29.52 Billion

≈ $20.00 Million USD Cash + Short-term Investments

Total Assets

₩3.22 Trillion

≈ $2.18 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Yuhan Corp.'s Asset Resilience Ratio has changed over time. See 000100 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Yuhan Corp.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Yuhan Corp..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩29.52 Billion	0.92%
Total Liquid Assets	₩29.52 Billion	0.92%

Asset Resilience Insights

Limited Liquidity: Yuhan Corp. maintains only 0.92% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Yuhan Corp. Industry Peers by Asset Resilience Ratio

Compare Yuhan Corp.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Yuhan Corp. (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Yuhan Corp..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.92%	₩29.52 Billion ≈ $20.00 Million	₩3.22 Trillion ≈ $2.18 Billion	+0.09pp
2024-12-31	0.82%	₩24.23 Billion ≈ $16.42 Million	₩2.94 Trillion ≈ $1.99 Billion	+0.01pp
2023-12-31	0.81%	₩22.75 Billion ≈ $15.41 Million	₩2.81 Trillion ≈ $1.91 Billion	-1.40pp
2022-12-31	2.21%	₩54.68 Billion ≈ $37.06 Million	₩2.47 Trillion ≈ $1.68 Billion	-5.22pp
2021-12-31	7.44%	₩183.22 Billion ≈ $124.16 Million	₩2.46 Trillion ≈ $1.67 Billion	+3.59pp
2020-12-31	3.85%	₩92.11 Billion ≈ $62.42 Million	₩2.39 Trillion ≈ $1.62 Billion	-2.81pp
2019-12-31	6.66%	₩140.94 Billion ≈ $95.51 Million	₩2.12 Trillion ≈ $1.43 Billion	-4.10pp
2018-12-31	10.76%	₩233.84 Billion ≈ $158.47 Million	₩2.17 Trillion ≈ $1.47 Billion	-0.94pp
2017-12-31	11.70%	₩245.00 Billion ≈ $166.03 Million	₩2.09 Trillion ≈ $1.42 Billion	-0.11pp
2016-12-31	11.81%	₩241.58 Billion ≈ $163.71 Million	₩2.05 Trillion ≈ $1.39 Billion	+10.18pp
2015-12-31	1.63%	₩30.66 Billion ≈ $20.78 Million	₩1.88 Trillion ≈ $1.27 Billion	-15.20pp
2014-12-31	16.83%	₩271.99 Billion ≈ $184.32 Million	₩1.62 Trillion ≈ $1.10 Billion	+11.27pp
2013-12-31	5.56%	₩84.16 Billion ≈ $57.03 Million	₩1.51 Trillion ≈ $1.03 Billion	-5.54pp
2012-12-31	11.10%	₩155.80 Billion ≈ $105.58 Million	₩1.40 Trillion ≈ $950.85 Million	+0.19pp
2011-12-31	10.92%	₩143.48 Billion ≈ $97.23 Million	₩1.31 Trillion ≈ $890.52 Million	-5.38pp
2010-12-31	16.30%	₩204.61 Billion ≈ $138.66 Million	₩1.26 Trillion ≈ $850.84 Million	+8.95pp
2009-12-31	7.35%	₩83.35 Billion ≈ $56.49 Million	₩1.13 Trillion ≈ $769.03 Million	-0.69pp
2008-12-31	8.04%	₩83.48 Billion ≈ $56.58 Million	₩1.04 Trillion ≈ $704.04 Million	+0.72pp
2007-12-31	7.31%	₩72.94 Billion ≈ $49.43 Million	₩997.19 Billion ≈ $675.78 Million	+2.23pp
2006-12-31	5.09%	₩47.91 Billion ≈ $32.47 Million	₩941.40 Billion ≈ $637.97 Million	-4.19pp
2005-12-31	9.28%	₩83.42 Billion ≈ $56.54 Million	₩898.67 Billion ≈ $609.01 Million	+0.93pp
2004-12-31	8.35%	₩63.87 Billion ≈ $43.29 Million	₩764.90 Billion ≈ $518.36 Million	-0.88pp
2003-12-31	9.23%	₩60.90 Billion ≈ $41.27 Million	₩659.58 Billion ≈ $446.99 Million	-4.81pp
2002-12-31	14.04%	₩88.60 Billion ≈ $60.04 Million	₩631.04 Billion ≈ $427.64 Million	-1.03pp
2001-12-31	15.07%	₩87.95 Billion ≈ $59.60 Million	₩583.76 Billion ≈ $395.60 Million	-0.19pp
2000-12-31	15.25%	₩84.83 Billion ≈ $57.49 Million	₩556.14 Billion ≈ $376.89 Million	--

pp = percentage points

About Yuhan Corp.

KO:000100 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$3.90 Billion

₩5.76 Trillion KRW

Market Cap Rank

#4255 Global

#105 in Korea

Share Price

₩78200.00

Change (1 day)

-1.14%

52-Week Range

₩72400.00 - ₩135800.00

All Time High

₩163700.00